However, the identification of Hif-1α—overexpressed in BRAF-like tumours—as one of the orchestrators of metabolic processes in these tumours, likewise in melanoma [9], opens new intriguing therapeutic perspectives. This evidence concerns the gene HIF1A and melanoma.